Posted by Michael Wonder on 19 Mar 2020
Insulin prices and pharmacy benefit manager rebates: pin the tail on the patient
19 March 2020 - Over the past 15 years, insulin prices have more than doubled.
Pharmaceutical companies have been on the receiving end of most of the blame, and the chorus of angry voices has grown louder given Speaker Nancy Pelosi’s H.R. 3 bill, which shows that Americans pay three times more for the same medicines than Europeans do.
